Tumor necrosis factor is dispensable for the success of immunogenic anticancer chemotherapy.

Oncoimmunology

1 juin 2013
Tumor necrosis factor is dispensable for the success of immunogenic anticancer chemotherapy.

Ma Y, Yamazaki T, Yang H, Kepp O, Galluzzi L, Zitvogel L, Smyth MJ, Kroemer G.